Skip to main content
Premium Trial:

Request an Annual Quote

InforSense Makes GenSense Software Affy-Compatible

NEW YORK (GenomeWeb News) - InforSense said today that it has joined the Affymetrix GeneChip-compatible Applications Program in order to make its GenSense software compatible with the GeneChip platform.
 
Affymetrix has also become a member of InforSense's Open Workflow Partner Network, the company said.
 
InforSense said the integration will allow researchers to analyze and interpret information from Affy's Genome-Wide Human SNP 5.0 and SNP 6.0 arrays.
 
The company said its embedded analytics software now offers access to Affy's software for analyzing loss of heterozygosity and copy number variation, and several of Affy's calling algorithms, including BRLMM, BRLMM-p, and Birdseed.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.